Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
Fujikawa
K
K
Aratake
K
K
Kawakami
A
A
Aramaki
T
T
Iwanaga
N
N
Izumi
Y
Y
Arima
K
K
Kamachi
M
M
Tamai
M
M
Huang
M
M
Nakamura
H
H
Nishiura
Y
Y
Origuchi
T
T
Ida
H
H
Eguchi
K
K
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D016207:Cytokines / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D050781:Transcranial Magnetic Stimulation; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab